By Lucien Hordijk & Daan Marselis Most of the demand for (refresher) training courses for doctors in the Netherlands is fulfilled by industry- sponsored programmes. …

Two decades of EU market protection of ‘orphan’ (rare disease) medicines have greatly benefitted the industry. According to research by The Investigative Desk, published in …

New innovative medicines should be made available to European citizens more quickly. That is why the European Medicines Agency updates the process for market authorisation. …